Researcher
Filip Van den Bosch
- Keywords:Psoriatic arthritis, Biological DMARDs, Spondyloarthritis, Rheumatoid arthritis, Targeted Synthetic DMARDs, Ankylosing spondylitis
- Disciplines:Immunomodulation therapy, Other clinical sciences not elsewhere classified
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Oct 2011 → 30 Sep 2018
Projects
1 - 5 of 5
- Microbes-4-Immunity: single-cell based sorting and investigation of the functional microbiome in intestinal and extra-intestinal immune homeostasis.From1 Jan 2022 → TodayFunding: BOF - projects
- Deciphering the functional phenotype of ?d T cells in spondyloarthritis.From1 Nov 2021 → TodayFunding: FWO fellowships
- Role of intestinal barrier dysfunction for the pathogenesis of spondyloarthritisFrom1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Dynamic modulation of disease progression in chronic gut and joint inflammation in spondyloarthritidesFrom1 Jan 2017 → 31 Oct 2022Funding: BOF - Concerted Research Project from 1994
- Relation between inflammation of the gut and arthritis in spondyloarthropathy: cellular mechanisms and therapeutical implicationsFrom1 Jan 2007 → 31 Oct 2012Funding: BOF - Concerted Research Project from 1994
Publications
31 - 40 of 214
- Response to : ‘Finding the right one’ by Zanwar(2022)
Authors: Thomas Renson, Filip Van den Bosch
- Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis(2022)
Authors: Uta Kiltz, Annelies Boonen, Désirée van der Heijde, Wilson Bautista-Molano, Ruben Burgos Vargas, Praveena Chiowchanwisawakit, Bassel El-Zorkany, Inna Gaydukova, Pal Geher, Laure Gossec, et al.
Pages: 2054 - 2062 - FRI0304U+2005serum IGG-undergalactosylation profiles reflect cumulative exposure to systemic inflammation in spondyloarthritis patients(2021)Volume: 79
Authors: Ann-Sophie De Craemer, Z. Lukasik, L. Meuris, Liselotte Deroo, Thomas Renson, Manouk de Hooge, Annelies Van Hecke, Filip Van den Bosch
Pages: 742.1 - 742 - Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial(2021)
Authors: Anna Molto, Clementina López-Medina, Filip Van den Bosch, Annelies Boonen, Casper Webers, Emanuelle Dernis, Floris A van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet, et al.
Pages: 1436 - 1444 - TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexate(2021)
Authors: Ann-Sophie De Craemer, Thomas Renson, Roos Colman, Filip Van den Bosch
Pages: 4880 - 4883 - Measuring treatment effect on psoriatic arthritis-related domains : insights from the SPIRIT-H2H study at weeks 24 and 52(2021)
Authors: Frank Behrens, Soyi Liu Leage, Christophe Sapin, Celine El Baou, Inmaculada De la Torre, Gabriella Meszaros, Georg Schett, Bernard Combe, Filip Van den Bosch, Laure Gossec
Pages: 4943 - 4954 - Secukinumab efficacy on enthesitis in patients with ankylosing spondylitis : pooled analysis of four pivotal phase III studies(2021)
Authors: Georg Schett, Xenofon Baraliakos, Filip Van den Bosch, Atul Deodhar, Mikkel Ostergaard, Ayan Das Gupta, Shephard Mpofu, Todd Fox, Adam Winseck, Brian Porter, et al.
Pages: 1251 - 1258 - Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission : efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)(2021)
Authors: Robert B. M. Landewé, Lianne S. Gensler, Denis Poddubnyy, Proton Rahman, Maja Hojnik, Xiaoqi Li, Soyi Liu Leage, David Adams, Hilde Carlier, Filip Van den Bosch, et al.
Pages: 1022 - 1030 - Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis(2021)
Authors: Sophie De Mits, Ann-Sophie De Craemer, Liselotte Deroo, Thomas Renson, Filip Van den Bosch
Pages: 1638 - 1640 - Patient-reported outcomes in psoriatic arthritis patients with an inadequate response to biologic disease-modifying antirheumatic drugs : SELECT-PsA 2(2021)
Authors: Vibeke Strand, Filip Van den Bosch, Roberto Ranza, Ying-Ying Leung, Edit Drescher, Patrick Zueger, Christopher D. Saffore, Apinya Lertratanakul, Ralph Lippe, Peter Nash
Pages: 1827 - 1844